Geneart Posts 16 Percent Revenue Growth for Q3 | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Geneart today reported third-quarter revenue growth of 16 percent and a sharp increase in its profit.

The German synthetic genomics firm reported revenues of €5 million ($6.9 million) for the quarter compared to €4.3 million for the third quarter of 2009.

Its earnings before interest and taxes was €135,000, up sharply from €25,000 for Q3 2009.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.